- Home
- HBM vs NUVL Comparison
HBM vs NUVL Comparison
Compare HBM & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBM
- NUVL
- Stock Information
- Founded
- HBM 1927
- NUVL 2017
- Country
- HBM Canada
- NUVL United States
- Employees
- HBM N/A
- NUVL N/A
- Industry
- HBM Metal Mining
- NUVL Biotechnology: Pharmaceutical Preparations
- Sector
- HBM Basic Materials
- NUVL Health Care
- Exchange
- HBM Nasdaq
- NUVL Nasdaq
- Market Cap
- HBM 5.4B
- NUVL 6.0B
- IPO Year
- HBM N/A
- NUVL 2021
- Fundamental
- Price
- HBM $17.07
- NUVL $84.80
- Analyst Decision
- HBM
- NUVL Strong Buy
- Analyst Count
- HBM 0
- NUVL 9
- Target Price
- HBM N/A
- NUVL $118.89
- AVG Volume (30 Days)
- HBM 8.3M
- NUVL 397.7K
- Earning Date
- HBM 11-12-2025
- NUVL 11-11-2025
- Dividend Yield
- HBM 0.08%
- NUVL N/A
- EPS Growth
- HBM 216.33
- NUVL N/A
- EPS
- HBM 0.72
- NUVL N/A
- Revenue
- HBM $2,202,000,000.00
- NUVL N/A
- Revenue This Year
- HBM $13.99
- NUVL N/A
- Revenue Next Year
- HBM N/A
- NUVL N/A
- P/E Ratio
- HBM $23.66
- NUVL N/A
- Revenue Growth
- HBM 8.31
- NUVL N/A
- 52 Week Low
- HBM $5.95
- NUVL $55.54
- 52 Week High
- HBM $17.21
- NUVL $106.32
- Technical
- Relative Strength Index (RSI)
- HBM 79.88
- NUVL 55.84
- Support Level
- HBM $15.04
- NUVL $82.00
- Resistance Level
- HBM $16.46
- NUVL $86.34
- Average True Range (ATR)
- HBM 0.56
- NUVL 3.42
- MACD
- HBM 0.10
- NUVL 0.18
- Stochastic Oscillator
- HBM 98.99
- NUVL 65.38
About HBM Hudbay Minerals Inc. (Canada)
Hudbay Minerals Inc is a Canadian mining company with its operations, property developments, and exploration activities across the United States. The mines that Hudbay operates are located in Manitoba, Canada, Arizona, United States; and Peru. The company is principally focused on the discovery, production, and marketing of base and precious metals. Hudbay produces copper concentrate, which contains copper, gold, and silver, as well as zinc metal. More than half the company's revenue is attributable to the copper business. The company sells copper concentrates to smelters across Asia, America, and Europe, and sells Zinc metal, another source of revenue, to industrial customers across North America.
About NUVL Nuvalent Inc.
Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.